A Prospective, Single-center, Open-label Case Series Evaluating the Clinical Outcomes of Lyopreserved Placental Membrane Containing Viable Cells in the Treatment of Chronic Wounds.

CONCLUSIONS: This is the first case series reporting the clinical outcomes of vLPM for the management of chronic wounds. Results of this study demonstrate similar closure rates to those previously reported for vCPM. These results suggest potential clinical equivalence between the 2 formulations, with vLPM providing the added convenience of long-term room-temperature storage (current shelf life of 12 months). PMID: 30924793 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/30924793?dopt=Abstract

Source: Wounds - March 31, 2019 Category: General Medicine Tags: Wounds Source Type: research